Art Papier, M.D., CEO of VisualDx, says darker skin tones have been underrepresented in dermatology resources for decades and ...

The American Academy of Ophthalmology (AAO) kicked off their 2026 annual meeting today in New Orleans, with an authentic second-line parade of musicians, dancers and performers inviting conference ...

Large language models (LLMs) are now bringing new attention to the category, according to Art Papier, M.D., CEO of VisualDx. He also cautions that clinicians shouldn’t assume these tools are always ...

Real-world data at the 2026 Fall Clinical Dermatology Conference show dupilumab in children with atopic dermatitis cuts new ...

Experts at Fall Clinical Derm 2026 urge early JAK inhibitors over systemic steroids for atopic dermatitis and long-term vitiligo treatment, saying boxed-warning risks are overstated. It’s recommended ...

The 2026 Pharmacy Benefit Management Institute Annual National Conference was held Sept. 10-11 in Orlando, Florida. Here is a ...

Sagimet CEO David Happel says oral denifanstat could sharply cut antibiotic use in acne and be used before patients ever need ...

Sagimet Biosciences’ denifanstat oral acne pill shows rapid, sustained lesion cuts and higher clear-skin rates in phase 3, ...

Sagimet Biosciences has begun screening patients for a U.S. phase 3 trial of denifanstat, an investigational once-daily oral ...

In this conversation, Alison Pritchard, Ph.D., explains how ADHD and sleep problems can form a cycle in children and shares findings from ‘What Matters to Caregivers of Youth Wi ...

In this month’s episode of Tuning In to the C-Suite, Managing Editor Peter Wehrwein talks with Rick Bates, MBA, president and CEO of RxSense. In his conversation with Wehrwein, Bates described RxSense ...

New guidelines for acute low back pain favors self-care, NSAIDs, physical therapy and acupuncture over routine imaging and first-line opioids. Imaging and opioids should not be first-line treatment ...